Newcastle disease virus (NDV): brief history of its oncolytic strains.
about
Genetically engineered Newcastle disease virus for malignant melanoma therapyOncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cellsEnhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responsesOncolytic virus therapy for glioblastoma multiforme: concepts and candidatesTransient activation of the PI3K/Akt pathway promotes Newcastle disease virus replication and enhances anti-apoptotic signaling responsesNewcastle disease virus in Madagascar: identification of an original genotype possibly deriving from a died out ancestor of genotype IV.Recombinant Newcastle disease virus as a vaccine vectorGenetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.Phylogenetic and pathotypical analysis of two virulent Newcastle disease viruses isolated from domestic ducks in China.Oncolytic viruses: From bench to bedside with a focus on safety.Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cellsPreparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticlesSynthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine.Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer modelsGenetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma.Replication-selective oncolytic viruses in the treatment of cancer.Oncolytic viruses for cancer therapy II. Cell-internal factors for conditional growth in neoplastic cells.Proinflammatory response induced by Newcastle disease virus in tumor and normal cells.Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.Phylogenetic and Pathotypic Characterization of Newcastle Disease Viruses Circulating in South China and Transmission in Different BirdsAn overview on the development of newcastle disease virus as an anti-cancer therapy.Interferon regulatory factor 3 is a key regulation factor for inducing the expression of SAMHD1 in antiviral innate immunity.A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging.Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240Measles virus for cancer therapy.Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo.Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity.Detection of Newcastle disease virus minor genetic variants by modified single-stranded conformational polymorphism analysis.Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets.Update on oncolytic viral therapy - targeting angiogenesisNewcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme.Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and HostIntratumoral immunotherapy for melanoma.Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase.Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma.Therapeutic potential of oncolytic Newcastle disease virus: a critical review.Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection.Novel oncolytic viral therapies in patients with thoracic malignancies.The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling.Cell-type-specific innate immune response to oncolytic Newcastle disease virus.
P2860
Q24597831-EACE2039-7F03-4265-BC18-9943BC4AF5ACQ24602706-08F0EE33-10CC-4E2A-BCE6-7BCEE94FE2E0Q24631361-9464A5F8-CF2C-4067-B44D-E12AC1E9F0EBQ27007519-2AAB1C0B-CDC9-4731-8B2E-DC9A2B299F88Q33618766-EF65F615-E774-441A-88EC-8C3A729D6DFDQ33749893-AA411912-605C-40F2-885A-05887E28B459Q33850246-48551F0D-B3A0-4B58-B751-BBA947F142B4Q34028464-F6E183A6-0178-4CD1-A42B-87E1EF31A7B7Q34031795-DE7651C3-79EC-4888-B55A-D66686F9FAAAQ34044071-E1BF7D3B-51C7-4E3A-AB77-0FCCBFCF4402Q34227719-FD05B79A-0C91-43E0-993A-35B2B0775646Q35080032-B2CA761A-4728-4AFF-974D-E61DC61F2748Q35491580-FFBFC4A8-F29E-42C6-9980-56730D80FF75Q35587389-48632935-2DB9-479D-AABA-0E79A1FEDDCFQ35699080-77D89DF5-7775-4E38-8267-321AB064865AQ35912403-EE6F48CF-E39C-4AB1-980A-C1A0BE628BE5Q36102568-EE624C64-8289-4845-B140-5902C6240918Q36308045-5D092B00-58E4-47DA-BBDD-8E696E5480BEQ36318166-9F06E73C-AFD1-4DB4-8F57-8B049F077821Q36558949-1D1A190F-9376-4A7B-8A7D-98A52F17EC12Q36568040-35C700F5-5B30-4049-990E-D2E776E1C978Q37093160-C2611367-A0AA-48E6-ADEB-A32944917C95Q37126192-EB12B475-2CBC-4CAB-9E21-517F6E5C33C9Q37197511-DECDB9CB-5039-42E1-8B6C-27F07EEC0E62Q37388577-203ADBD4-98F1-4095-99E5-1767D61B61CEQ37611840-CAEE4A07-3174-4BC1-9D25-3459F501F30EQ37651860-CEF90242-3522-445F-8326-36A3C45D300EQ37725507-1739488F-1C7B-4BAE-A19D-A18964D794E2Q38033591-F7DA188A-6768-4201-AB54-5061D72132ACQ38128561-F3523956-4D7D-4FE3-B24E-D2640857571FQ38253056-88F0E949-FFF6-416C-8B98-BAC861D93082Q38369289-5BE6B5DB-7D20-461F-BC90-B066872A2217Q38518518-9EA3E54A-43FB-4AB5-9343-CEB93A8DA36BQ38700909-5116845A-E33B-47A0-A144-84B92A0F763EQ38860227-1B6E8A2D-AF3A-40EB-8E95-29CF28647BFDQ38924554-CA0451B6-53D9-43FA-B3E5-6EB61CD5E855Q39037822-168425C1-BE15-4A93-8BD5-F81E7484CAECQ39067827-04F99448-7DEB-4D17-8163-0F46660C1528Q39179082-47D15B07-57AC-4747-92D2-7CCAD95BF25BQ39312501-D7A72E1A-58FE-45B3-9D7C-2B75208BCFA4
P2860
Newcastle disease virus (NDV): brief history of its oncolytic strains.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Newcastle disease virus (NDV): brief history of its oncolytic strains.
@ast
Newcastle disease virus (NDV): brief history of its oncolytic strains.
@en
type
label
Newcastle disease virus (NDV): brief history of its oncolytic strains.
@ast
Newcastle disease virus (NDV): brief history of its oncolytic strains.
@en
prefLabel
Newcastle disease virus (NDV): brief history of its oncolytic strains.
@ast
Newcastle disease virus (NDV): brief history of its oncolytic strains.
@en
P1476
Newcastle disease virus (NDV): brief history of its oncolytic strains.
@en
P2093
Horvath JC
Sinkovics JG
P356
10.1016/S1386-6532(99)00072-4
P577
2000-02-01T00:00:00Z